To address whether expression of genes located in 2p15-p16.1increases in FL samples after histological transformation toaggressive B-cell lymphoma (e.g., DLBCL), we evaluatedwhether mRNA expression of genes in 2p15-p16.1 (i.e.BCL11A, PAPOLG, PUS10, and USP34) increased in 12FL cases after histological transformation to tFL using theNCBI GEO2R bioinformatics tool (Figure 4). The gene discussed is BCL11A; the disease is B-cell non-Hodgkin lymphoma.